Log In
Print this Print this

HyperAcute Pancreas, algenpantucel-L

  Manage Alerts
Collapse Summary General Information
Company NewLink Genetics Corp.
DescriptionAllogeneic cancer vaccine containing irradiated pancreatic tumor cells modified to express alpha 1,3-galactosyltransferase
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

U.S. - Fast Track (Treat pancreatic cancer);
U.S. - Orphan Drug (Treat pancreatic cancer);
U.S. - Special Protocol Assessment (Treat pancreatic cancer);
EU - Orphan Drug (Treat pancreatic cancer)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today